Targeting NRF2 for the Treatment of Friedreich’s Ataxia: A Comparison among Drugs
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting NRF2 for the Treatment of Friedreich’s Ataxia: A Comparison among Drugs
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 20, Issue 20, Pages 5211
Publisher
MDPI AG
Online
2019-10-21
DOI
10.3390/ijms20205211
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Redox regulation by NRF2 in aging and disease
- (2019) Cody J. Schmidlin et al. FREE RADICAL BIOLOGY AND MEDICINE
- Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases
- (2019) Antonio Cuadrado et al. NATURE REVIEWS DRUG DISCOVERY
- Targeting ferroptosis: A novel therapeutic strategy for the treatment of mitochondrial disease-related epilepsy
- (2019) Amanda H. Kahn-Kirby et al. PLoS One
- Insight into the mechanism of action of dimethyl fumarate in multiple sclerosis
- (2019) Sudhir Kumar Yadav et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Therapeutic Prospects for Friedreich’s Ataxia
- (2019) Siyuan Zhang et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- New developments in pharmacotherapy for Friedreich ataxia
- (2019) Alexandra Clay et al. EXPERT OPINION ON PHARMACOTHERAPY
- Dimethyl fumarate dosing in humans increases frataxin expression: A potential therapy for Friedreich’s Ataxia
- (2019) Mittal Jasoliya et al. PLoS One
- Nrf2 Induction Re-establishes a Proper Neuronal Differentiation Program in Friedreich’s Ataxia Neural Stem Cells
- (2019) Piergiorgio La Rosa et al. Frontiers in Cellular Neuroscience
- Structure of the human frataxin-bound iron-sulfur cluster assembly complex provides insight into its activation mechanism
- (2019) Nicholas G. Fox et al. Nature Communications
- Therapeutic efficacy of dimethyl fumarate in relapsing-remitting multiple sclerosis associates with ROS pathway in monocytes
- (2019) Karl E. Carlström et al. Nature Communications
- Redox Signaling Mechanisms in Nervous System Development
- (2018) Mauricio Olguín-Albuerne et al. ANTIOXIDANTS & REDOX SIGNALING
- The macrophage heme-heme oxygenase-1 system and its role in inflammation
- (2018) Vijith Vijayan et al. BIOCHEMICAL PHARMACOLOGY
- KEAP1 inhibition is neuroprotective and suppresses the development of epilepsy
- (2018) Tawfeeq Shekh-Ahmad et al. BRAIN
- Aberrant regulation of the GSK‐3β/NRF2 axis unveils a novel therapy for adrenoleukodystrophy
- (2018) Pablo Ranea‐Robles et al. EMBO Molecular Medicine
- The role of Nrf2 signaling in counteracting neurodegenerative diseases
- (2018) Albena T. Dinkova-Kostova et al. FEBS Journal
- Response to medical and a novel dietary treatment in newborn screen identified patients with ethylmalonic encephalopathy
- (2018) M. Boyer et al. MOLECULAR GENETICS AND METABOLISM
- Canonical and non-canonical mechanisms of Nrf2 activation
- (2018) Carlos Alfredo Silva-Islas et al. PHARMACOLOGICAL RESEARCH
- Transcription Factor NRF2 as a Therapeutic Target for Chronic Diseases: A Systems Medicine Approach
- (2018) Antonio Cuadrado et al. PHARMACOLOGICAL REVIEWS
- Novel Nrf2-Inducer Prevents Mitochondrial Defects and Oxidative Stress in Friedreich’s Ataxia Models
- (2018) Rosella Abeti et al. Frontiers in Cellular Neuroscience
- Emerging Understanding of the Mechanism of Action for Dimethyl Fumarate in the Treatment of Multiple Sclerosis
- (2018) Elizabeth A. Mills et al. Frontiers in Neurology
- Current and Emerging Treatment Modalities for Leber’s Hereditary Optic Neuropathy: A Review of the Literature
- (2018) Anna Theodorou-Kanakari et al. ADVANCES IN THERAPY
- Dimethyl fumarate treatment in multiple sclerosis: Recent advances in clinical and immunological studies
- (2018) Gwendoline Montes Diaz et al. AUTOIMMUNITY REVIEWS
- Overview on the Effects of N-Acetylcysteine in Neurodegenerative Diseases
- (2018) Giuseppe Tardiolo et al. MOLECULES
- N-acetylcysteine amide provides neuroprotection via Nrf2-ARE pathway in a mouse model of traumatic brain injury
- (2018) Yuan Zhou et al. Drug Design Development and Therapy
- Safety, pharmacodynamics, and potential benefit of omaveloxolone in Friedreich ataxia
- (2018) David R. Lynch et al. Annals of Clinical and Translational Neurology
- Pharmacological therapeutics in Friedreich ataxia: the present state
- (2017) Cassandra Strawser et al. Expert Review of Neurotherapeutics
- Oxidative stress in Duchenne muscular dystrophy: focus on the NRF2 redox pathway
- (2017) Sara Petrillo et al. HUMAN MOLECULAR GENETICS
- Nrf2-Inducers Counteract Neurodegeneration in Frataxin-Silenced Motor Neurons: Disclosing New Therapeutic Targets for Friedreich’s Ataxia
- (2017) Sara Petrillo et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Therapies for mitochondrial diseases and current clinical trials
- (2017) Ayman W. El-Hattab et al. MOLECULAR GENETICS AND METABOLISM
- Nrf2, cellular redox regulation, and neurologic implications
- (2017) Eduardo E. Benarroch NEUROLOGY
- RTA-408 Protects Kidney from Ischemia-Reperfusion Injury in Mice via Activating Nrf2 and Downstream GSH Biosynthesis Gene
- (2017) Peng Han et al. Oxidative Medicine and Cellular Longevity
- Pharmacological therapeutics in Friedreich ataxia: the present state
- (2017) Cassandra Strawser et al. Expert Review of Neurotherapeutics
- Functions of NQO1 in Cellular Protection and CoQ10 Metabolism and its Potential Role as a Redox Sensitive Molecular Switch
- (2017) David Ross et al. Frontiers in Physiology
- Glutathione as a Redox Biomarker in Mitochondrial Disease—Implications for Therapy
- (2017) et al. Journal of Clinical Medicine
- Repurposing the NRF2 Activator Dimethyl Fumarate as Therapy Against Synucleinopathy in Parkinson's Disease
- (2016) Isabel Lastres-Becker et al. ANTIOXIDANTS & REDOX SIGNALING
- Regulation of DJ-1 by Glutaredoxin 1 in Vivo: Implications for Parkinson’s Disease
- (2016) William M. Johnson et al. BIOCHEMISTRY
- Establishment and Maintenance of Primary Fibroblast Repositories for Rare Diseases—Friedreich's Ataxia Example
- (2016) Yanjie Li et al. BIOPRESERVATION AND BIOBANKING
- Idebenone in Friedreich ataxia and Leber’s hereditary optic neuropathy: close mechanisms, similar therapy?: Table 1
- (2016) Manuel Schiff et al. BRAIN
- Friedreich ataxia-induced pluripotent stem cell-derived neurons show a cellular phenotype that is corrected by a benzamide HDAC inhibitor
- (2016) Franca Codazzi et al. HUMAN MOLECULAR GENETICS
- Frataxin silencing alters microtubule stability in motor neurons: implications for Friedreich’s ataxia
- (2016) Emanuela Piermarini et al. HUMAN MOLECULAR GENETICS
- 'Mitochondrial energy imbalance and lipid peroxidation cause cell death in Friedreich’s ataxia'
- (2016) R Abeti et al. Cell Death & Disease
- Establishment and Maintenance of Primary Fibroblast Repositories for Rare Diseases—Friedreich's Ataxia Example
- (2016) Yanjie Li et al. Biopreservation and Biobanking
- Dual regulation of transcription factor Nrf2 by Keap1 and by the combined actions of β-TrCP and GSK-3
- (2015) John D. Hayes et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Sulforaphane attenuation of experimental diabetic nephropathy involves GSK-3 beta/Fyn/Nrf2 signaling pathway
- (2015) Guoguo Shang et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Targeting lipid peroxidation and mitochondrial imbalance in Friedreich's ataxia
- (2015) Rosella Abeti et al. PHARMACOLOGICAL RESEARCH
- Dyclonine rescues frataxin deficiency in animal models and buccal cells of patients with Friedreich's ataxia
- (2014) Sunil Sahdeo et al. HUMAN MOLECULAR GENETICS
- Frataxin Silencing Inactivates Mitochondrial Complex I in NSC34 Motoneuronal Cells and Alters Glutathione Homeostasis
- (2014) Barbara Carletti et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The Nrf2 regulatory network provides an interface between redox and intermediary metabolism
- (2014) John D. Hayes et al. TRENDS IN BIOCHEMICAL SCIENCES
- Frataxin Deficiency Leads to Defects in Expression of Antioxidants and Nrf2 Expression in Dorsal Root Ganglia of the Friedreich's Ataxia YG8R Mouse Model
- (2013) Yuxi Shan et al. ANTIOXIDANTS & REDOX SIGNALING
- New Insights into Intracellular Locations and Functions of Heme Oxygenase-1
- (2013) Louise L. Dunn et al. ANTIOXIDANTS & REDOX SIGNALING
- Frataxin Deficiency Leads to Reduced Expression and Impaired Translocation of NF-E2-Related Factor (Nrf2) in Cultured Motor Neurons
- (2013) Valentina D'Oria et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Co-enzyme Q10and idebenone use in Friedreich's ataxia
- (2013) Michael H Parkinson et al. JOURNAL OF NEUROCHEMISTRY
- Glutathione: A redox signature in monitoring EPI-743 therapy in children with mitochondrial encephalomyopathies
- (2013) Anna Pastore et al. MOLECULAR GENETICS AND METABOLISM
- Natural product-derived pharmacological modulators of Nrf2/ARE pathway for chronic diseases
- (2013) Hemant Kumar et al. NATURAL PRODUCT REPORTS
- Analysis of GSH and GSSG after derivatization with N-ethylmaleimide
- (2013) Daniela Giustarini et al. Nature Protocols
- Glutathione synthesis
- (2012) Shelly C. Lu BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- EPI-743 reverses the progression of the pediatric mitochondrial disease—Genetically defined Leigh Syndrome
- (2012) Diego Martinelli et al. MOLECULAR GENETICS AND METABOLISM
- Dysregulation of Glutathione Homeostasis in Neurodegenerative Diseases
- (2012) William M. Johnson et al. Nutrients
- A randomized placebo-controlled trial of idebenone in Leber’s hereditary optic neuropathy
- (2011) Thomas Klopstock et al. BRAIN
- Cruciferous Vegetable Phytochemical Sulforaphane Affects Phase II Enzyme Expression and Activity in Rat Cardiomyocytes through Modulation of Akt Signaling Pathway
- (2011) Emanuela Leoncini et al. JOURNAL OF FOOD SCIENCE
- Friedreich's ataxia: Pathology, pathogenesis, and molecular genetics
- (2011) Arnulf H. Koeppen JOURNAL OF THE NEUROLOGICAL SCIENCES
- Mammalian Frataxin: An Essential Function for Cellular Viability through an Interaction with a Preformed ISCU/NFS1/ISD11 Iron-Sulfur Assembly Complex
- (2011) Stéphane Schmucker et al. PLoS One
- Friedreich Ataxia: Molecular Mechanisms, Redox Considerations, and Therapeutic Opportunities
- (2010) Renata Santos et al. ANTIOXIDANTS & REDOX SIGNALING
- Blood cells from Friedreich ataxia patients harbor frataxin deficiency without a loss of mitochondrial function
- (2010) Mary A. Selak et al. MITOCHONDRION
- The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1
- (2010) Masaaki Komatsu et al. NATURE CELL BIOLOGY
- Frataxin deficiency induces Schwann cell inflammation and death
- (2009) Chunye Lu et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Idebenone: An emerging therapy for Friedreich ataxia
- (2009) Thomas Meier et al. JOURNAL OF NEUROLOGY
- Impaired Nuclear Nrf2 Translocation Undermines the Oxidative Stress Response in Friedreich Ataxia
- (2009) Vincent Paupe et al. PLoS One
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More